Fragment-Based Drug Discovery Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Fragment-Based Drug Discovery Market
1.1. Definition and Scope
1.1.1. Definition of Fragment-Based Drug Discovery
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Fragment-Based Drug Discovery Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Fragment-Based Drug Discovery Market By Type
1.2.3. Fragment-Based Drug Discovery Market By Technique
1.2.4. Fragment-Based Drug Discovery Market By End-User
1.2.5. Fragment-Based Drug Discovery Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Fragment-Based Drug Discovery Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Fragment-Based Drug Discovery Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2022
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Fragment-Based Drug Discovery Market By Type
4.1. Introduction
4.2. Fragment-Based Drug Discovery Revenue By Type
4.2.1. Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast, By Type, 2020-2032
4.2.2. Library Screening
4.2.2.1. Library Screening Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.3. Fragment Screening
4.2.3.1. Fragment Screening Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
4.2.4. Fragment Optimization
4.2.4.1. Fragment Optimization Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 5. Fragment-Based Drug Discovery Market By Technique
5.1. Introduction
5.2. Fragment-Based Drug Discovery Revenue By Technique
5.2.1. Fragment-Based Drug Discovery Revenue (USD Billion) and Technique, By Type, 2020-2032
5.2.2. X-Ray Crystallography
5.2.2.1. X-Ray Crystallography Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Nuclear Magnetic Resonance
5.2.3.1. Nuclear Magnetic Resonance Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Surface Plasmon Resonance
5.2.4.1. Surface Plasmon Resonance Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Other Screening Techniques
5.2.5.1. Other Screening Techniques Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Fragment-Based Drug Discovery Market By End-User
6.1. Introduction
6.2. Fragment-Based Drug Discovery Revenue By End-User
6.2.1. Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast, By End-User, 2020-2032
6.2.2. Contract Research Organizations (CROs)
6.2.2.1. Contract Research Organizations (CROs) Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Academic & Research Institutions
6.2.3.1. Academic & Research Institutions Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Biopharmaceutical Companies
6.2.4.1. Biopharmaceutical Companies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. North America Fragment-Based Drug Discovery Market By Country
7.1. North America Fragment-Based Drug Discovery Market Overview
7.2. U.S.
7.2.1. U.S. Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
7.2.2. U.S. Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
7.2.3. U.S. Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
7.3. Canada
7.3.1. Canada Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
7.3.2. Canada Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
7.3.3. Canada Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
7.4. North America PEST Analysis
CHAPTER 8. Europe Fragment-Based Drug Discovery Market By Country
8.1. Europe Fragment-Based Drug Discovery Market Overview
8.2. U.K.
8.2.1. U.K. Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
8.2.2. U.K. Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
8.2.3. U.K. Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.3. Germany
8.3.1. Germany Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
8.3.2. Germany Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
8.3.3. Germany Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.4. France
8.4.1. France Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
8.4.2. France Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
8.4.3. France Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.5. Spain
8.5.1. Spain Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
8.5.2. Spain Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
8.5.3. Spain Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.6. Rest of Europe
8.6.1. Rest of Europe Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
8.6.2. Rest of Europe Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
8.6.3. Rest of Europe Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Fragment-Based Drug Discovery Market By Country
9.1. Asia Pacific Fragment-Based Drug Discovery Market Overview
9.2. China
9.2.1. China Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
9.2.2. China Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
9.2.3. China Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.3. Japan
9.3.1. Japan Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
9.3.2. Japan Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
9.3.3. Japan Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.4. India
9.4.1. India Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
9.4.2. India Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
9.4.3. India Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.5. Australia
9.5.1. Australia Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
9.5.2. Australia Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
9.5.3. Australia Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.6. South Korea
9.6.1. South Korea Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
9.6.2. South Korea Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
9.6.3. South Korea Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
9.7.2. Rest of Asia-Pacific Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
9.7.3. Rest of Asia-Pacific Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Fragment-Based Drug Discovery Market By Country
10.1. Latin America Fragment-Based Drug Discovery Market Overview
10.2. Brazil
10.2.1. Brazil Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
10.2.2. Brazil Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
10.2.3. Brazil Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.3. Mexico
10.3.1. Mexico Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
10.3.2. Mexico Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
10.3.3. Mexico Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.4. Rest of Latin America
10.4.1. Rest of Latin America Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
10.4.2. Rest of Latin America Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
10.4.3. Rest of Latin America Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Fragment-Based Drug Discovery Market By Country
11.1. Middle East & Africa Fragment-Based Drug Discovery Market Overview
11.2. GCC
11.2.1. GCC Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
11.2.2. GCC Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
11.2.3. GCC Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.3. South Africa
11.3.1. South Africa Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
11.3.2. South Africa Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
11.3.3. South Africa Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Type, 2020-2032
11.4.2. Rest of Middle East & Africa Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By Technique, 2020-2032
11.4.3. Rest of Middle East & Africa Fragment-Based Drug Discovery Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Fragment-Based Drug Discovery Market
12.1. Fragment-Based Drug Discovery Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Fragment-Based Drug Discovery Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. GE Healthcare Life Sciences
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2022
13.1.3.2. GE Healthcare Life Sciences 2022 Fragment-Based Drug Discovery Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Alveus Pharmaceuticals Pvt. Ltd.
13.3. Astex Pharmaceuticals
13.4. Charles River Laboratories International, Inc.
13.5. Beactica AB
13.6. Emerald BioStructures, Inc.
13.7. Crown Bioscience, Inc.
13.8. Evotec AG
13.9. Proteros Fragments GmbH
13.10. Kinetic Discovery Limited
13.11. Sprint Bioscience
13.12. Sygnature Discovery
13.13. Structure Based Design, Inc.
Frequently Asked Questions
What was the market size of the global fragment-based drug discovery in 2022?
The market size of fragment-based drug discovery was USD 1.1 billion in 2022.
What is the CAGR of the global fragment-based drug discovery (FBDD) market from 2023 to 2032?
The CAGR of fragment-based drug discovery is 14.0% during the analysis period of 2023 to 2032.
Which are the key players in the fragment-based drug discovery (FBDD) market?
The key players operating in the global market are including Alveus Pharmaceuticals Pvt. Ltd., Astex Pharmaceuticals, Charles River Laboratories International, Inc., Beactica AB, Emerald BioStructures, Inc., Crown Bioscience, Inc., Evotec AG, Proteros Fragments GmbH, Kinetic Discovery Limited, Sprint Bioscience, Sygnature Discovery and Structure Based Design, Inc.
Which region dominated the global fragment-based drug discovery (FBDD) market share?
North America held the dominating position in fragment-based drug discovery industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of fragment-based drug discovery during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global fragment-based drug discovery industry?
The current trends and dynamics in the fragment-based drug discovery industry include increasing demand for new drugs, collaboration between academia and industry, and rising prevalence of chronic diseases.
Which type held the maximum share in 2022?
The fragment screening held the maximum share of the fragment-based drug discovery industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
